Table 3.

Molecular cytogenetics of leukemic cells at diagnosis versus relapse

PatientStatusTEL/AML FISHCytogenetics
Interphase (%)Metaphases
NegativePositive+21TEL deletion+ider(21)3-150NegativePositive+ider(21)3-150
Dgn 38 62 60 44,XX,-X,-9,-12,+mar [4] 46,XX [9]3-151 
 Rel 29 71 48 46,XX [8] 
Dgn 20 80 20 65 46,XY [1] 
 Rel 91 85 47,XY,t(5;14)(q13;q33),+21 [17] 46,XY [3] 
Dgn 60 40 32 46,XY,del(12)(p13) [20] 
 Rel 34 66 66 — 
PatientStatusTEL/AML FISHCytogenetics
Interphase (%)Metaphases
NegativePositive+21TEL deletion+ider(21)3-150NegativePositive+ider(21)3-150
Dgn 38 62 60 44,XX,-X,-9,-12,+mar [4] 46,XX [9]3-151 
 Rel 29 71 48 46,XX [8] 
Dgn 20 80 20 65 46,XY [1] 
 Rel 91 85 47,XY,t(5;14)(q13;q33),+21 [17] 46,XY [3] 
Dgn 60 40 32 46,XY,del(12)(p13) [20] 
 Rel 34 66 66 — 

FISH indicates fluorescence in situ hybridization; dgn, diagnosis; rel, relapse.

F3-150

ider(21)(q10) t(12;21)(p13;q22).

F3-151

Note that subsequent interphase FISH analyses indicated that most leukemic cells retained both copies of chromosome 12 but had lost one copy of X and 9 (see “Results”).

or Create an Account

Close Modal
Close Modal